Clinical Trial Update: Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the Chinese herbal therapy Qiqi Shengmai Formula for Moyamoya vasculopathy is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Moyamoya Disease
• Moyamoya Syndrome

Drugs mentioned

• Qiqi Shengmai Formula

Snippet

Sponsor: Fudan University | Conditions: Moyamoya Disease, Moyamoya Syndrome | Phase 1 | Status: NOT_YET_RECRUITING